Semi-quantitative Western blot analysis of CD36 revealed that expression was upregulated in +NASH-MSC as compared to -NASH-MSC livers, which was not impacted by MSC treatment (Figure 2A). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatohepatitis.